Clinical Trials Browser

Phase 4 × Prostatic Neoplasms, Castration-Resistant × Clear all

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

NCT06706921 2024-11-27

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant

NCT03927391 2024-06-12

REDOSE

Phase 4 Completed

57 enrolled

Genitourinary

Prostatic Neoplasms, Castration-Resistant

Clinical Trials

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

REDOSE